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INHIBITION OF DIHYDROTESTOSTERONE FORMATION: AN EFFECTIVE MEANS 
OF BLOCKING ANDROGEN ACTION IN HAMSTER SEBACEOUS GLAND* 
s. L. HSlA. PH.D .. AND WALTER VO!G'T, PH.D. 
The action of androgens in the skin is of special 
dermatologic interest because the responsiveness 
of skin to androgens may contribute to the patho-
genesis of several common skin disorders. such as 
acne vulgaris. seborrhea, and male-pattern bald-
ness. Studies in several laboratories have shown 
that the skin not only responds to androgens 
(Strauss and Pochi, 19691 but also is an active site 
of androgen metabolism (Wotiz et al., 19S6; Cam-
eron et al., 1966; Rongone, 1966; Gallegos and 
Berliner. 1967: Gomez and Hsia, L968; Wilson and 
Walker, 1969; Faredin et al., 1969). Dihydrotes-
tosterone (DHT), the major metabolite of testos-
terone in.the skin (Gomez and Hsia, 1968). is a 
more potent androgen than testosterone: this was 
shown by bioassays on the ventral prostate and 
seminal vesicles of the rat (Vida, 1969). There is 
now convincing evidence that DHT formed from 
testosterone is an active form of androgen which 
mediates the hormone action hy intluencing gene 
expression in the prostate (Bruchovsky and Wil-
son, 1968; Anderson and Liao, 1968; Harper et al., 
1970; Bruchovsky, 1971). A study by Takayasu and 
Adachi (1972) indicated that DHT may also be an 
active and rogen in the sebaceous glands of ham-
sters. A study by Sansone and Reisner ( 1971) 
showed that acne-bearing skin on the face and 
back of both male and female patients converted 
testosterone into DHT at greater rates than skin 
from corresponding sites of normal controls. Exces-
sive androgen formation may be related to disease 
and this excessive formation could be averted by 
blocking DHT formation in the target organ; this 
approach has the special advantage of delivering 
the blocking agent directly to the skin by topical 
application. 
One of the enzymes of steroid metabolism in the 
skin studied in our laboratory during the past few 
years has been testosterone Sa-reductase. which 
mediates the formation of DH1'. We discovered 
that. a number of steroids can interfere with 
Sa-reductase activity and inhibit DHT formation. 
One of the most effective inhibitors is 4-andro-
sten-3-one-17 fJ-carboxylic acid (17 PC), which 
also exhibits antiandrogenic activity after topical 
application to the flank organ of the hamster. 
Sa-REDUCTASE AND iTS INHIBJ'I'ORS 
The stereospecific reduction of testosterone with 
NADPH to form DHT in target tissues is mediated 
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by testosterone 5a-reductase, an enzyme demon-
strated in the nuclei of the prostate (Bruchovsky 
and Wilson, 1968; Moore and Wilson. 1972). We 
found in human skin that most of the enzymic 
activity was associated with the microsomes: little 
activity could be detected in the purified nuclear 
fraction (Voigt et al., 1970). We reasoned that the ' 
formation of DHT in the skin is in the cytoplasm 
a11u that after its formation it is probably trans-
ported into the nuclei, perhaps by a receptor 
protein, in the same way that estradiol is carried 
into uterine cel1 nuclei (Jensen et al., 1968). 
Several steroid hormones (progesterone, deoxycor-
ticosterone, and androstenedione) inhibited the I 
enzyme during the conversion of testosterone to 
DH'1', probably by means of the structural resem-
blance of these steroids to testosterone and their 
ability to compete for the bindinl! site on the 
enzyme molecule. This explanation was substanti-
ated by results from mixed substrate experiments 
with progesterone and testosterone and by kinetic , 
studies with the two steroids, in which microsomal 
preparations of human skin were used as the source 
of the !)a-reductase. The results indicated that 
progesterone as well as testosterone could serve as 
the substrate for the Sa-reductase and that the two 
steroids mutually inhibit each other from undergo-
ing !)a-reduction, probably by competing for the 
same enzyme site (Voigt et aL. 1970). 
Competition among steroids for binding to en-
zyme sites is probably more common than we think 
and may be of fundamental endocrinologic signifi-
cance. We found another example in the enzyme 
17 P-hydroxysteroid dehydrogenase of rat skin. 
This enzyme mediates the inlerconversion of es-
tradiol -l7fJ and estrone. as well as of testosterone 
and androstenedione. Estradiol-17,8 and testoster-
one were found to competitively inhibit each other 
in undergoing the dehydrogenation mediated by 
this enzyme at Cl7 tDavis et al., 1972). Since 
enzymic transformation of a steroid can lead to lhe 
formation of metabolites with either more or less 
hormonal potencies. such transformations are inti-
mately related to the regulation of steroid hormone 
action. Therefore, interference with the enzymic 
transformation of a steroid hormone by another 
steroid hormone or metabolite may be a physi-
ologic means of balancing hormonal activities. 
To seek therapeutically useful inhibitors of the 
5a-redurtase, we tested structurally different ste-
roids for their ability to inhibit the formation of 
DHT from testosterone by the microsomal Sa-
reductase of human skin. Examination of effective 
inhibitors revealed some features that were com-
mon; these features were used as a guide for 
choosing from among many additional steroids. the 
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effective inhibitors of the Sa-reductase (Voigt and 
Hsia. 1973al. 
Figure 1 shows the structural formulas of 16 
steroids which illustrate the relation~:.hip between 
structure and inhibitory activity on 5a-reduction 
of testosterone. Compowtds l- lV are effective in -
hibitors because they a ll have the :3-keto-u • s truc· 
ture in ring A. This s tructural s imila rity to testo~:.­
terone apparently enable~ them to compete with 
the latter for binding with the .)a-reductase. ln a 
kinetic l:>tudy. progesterone (l) was found to have 
s lightly greater affinity than t estosterone for the 
enzyme (Voigt et al., 1970). Pregnenolone (V) 
differs [rom progesterone (I) in having a :~{j­
hydroxy-~ • instead of the 3-keto-~ • s tructure: it 
has li ttle inhi bitory activity. Dehydroepiandros ter· 
one (Vi ). which differs from androstenedione (U) in 
an analogous manner. also bas no inhibitory acti\ -
ity. Having a 3/j-hydroxyl in place of the 3-keto 
group. l-androstene-3/j. 17/J-diol (\ ' Il l is ineffec-
ti\'e as an inhibitor. DHT (VIIll , the product uf 
5a-reduction of testosterone. having a 3-keto and 
Sa-saturated ring A, also has no inhibitor.\' activ-
ity. Thus the :J-keto-u • structure i~:. a rigid require-
ment for effective inhibitors. Despite the :J-keto-.1. • 
s tructure. compounds IX. X. and XI are relatively 
poor inhibitors. They have another s tructural fea-
ture in common, i.e .. a lia-sub;.tituent. The bind-
ing of the s teroid to the enzyme may be at the a 
(rear) s ide of ring D. so tha t a 17t¥-suhstituent may 
hinder the b inding of the steroid to the enzyme and 
thus reduce its chance for binding. 
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Frc. I : Inhibitory effects of steroids on 5a·reduct ion 
of testosterone. The number under each steroid indicates 
percentage of inhibition. The assay mixtu re contained 
microsomes ( 10 mg protein) prepared from newborn pre-
putial skin collected at circumcision. 4- "C testosterone 
(10' dpm, 0.77 nmo1e). an NADPH-generating system, 
and the test steroid (10 nmole) in I ml of 0. 1 M citrate-
phosphate buffer. pH 5.6. 5a·reductase activity was 
measured by the amount of DHT and 5a-androstane-3a, 
17P-diol formed in 10 min at 37°C. (Data taken from 
Voigt et al., 1970, and Voigt and Hsia, 1972a.) 
(X II) ts a rather poor inhibitor. The binding of the 
steroid to the enzyme in the regions of rings Band 
C appears to be on the /3 (front) side. so that the 
11{:1-hydroxyl group in Xfl is detrimental to bind-
ing a nd a lso to the inhibitory effect. Any alteration 
in the steroid nucleus. such as deletion of I he 
19-methyl group (in 19-nortestosterone. XUJl or Cl 
(in A-norprogesterone, XIV). weakens or destroys 
the potency of the !:oteroid as an inhibitor. 
Despit e rigid structural requirements in ,·arious 
parts of the s teroid molecule, the effecti"e inhibi-
tors of testosterone 5a-reductase vary cons iderably 
in the 17.8-substituent group. This is evident in 
compounds l. III, a nd IV. each of which has a 
different hydrophilic 17,8-side chain. In contrast, 
cholestenon e (XV) wi th a hyd rocarbon s ide chain 
is ineffective as a n inh ibitor. Apparently. the 
hydrophilic nature of t he 17/j-side chain in com-
pounds I, 111, and lV is a necessary feature. 
a lthough within limits the size of the 17.8-side 
cha in may vary . 
We tested many other steroids nor listed here 
whose .. truct ures a nd inhibitory activity enforce 
the above generalization about the required st ruc-
tural features for an effective ;)a-reductase inhibi-
tor. To be therapeutically useful, however, a ste-
roid must have addi tional features besides its 
effectiveness in inh ibitinf' the !>a-reductase in the 
enzymic assa'. It must not ha"e undesi rable hor-mo~al activity and should not be a potential 
precursor of steroid hormones. For example, deoxy-
corticosterone (ill) is a potent inhibitor of 5a-
reduclase. but its influence on mineral metabolism 
eliminates it as a useful a ntiandrogen. Although 
a ndrostened ione (II) can compete with tebtm;ter-
one in the enzvmic reaction, it can be transformed 
into testosten;ne in the ttssue tGomez a nd Hsia, 
1968) and is therefore an a ndrogen instead of an 
a ntiandrogen. Although progesterone (!) has an-
tiandrogenic properties as evidenced by the chick 
comb test (Dorfman, 1965). it is a precursor for the 
biosynthes is of androgen ic steroids and is therefore 
not an ideal ant iandrogenic agen t. Severa l ether;; 
and esters of testosterone. which inhibited the 
5a-reduclase !Voigt and Hsia. 1973al. were also 
eliminated because of the possibility of their re-
leasing testosterone after hydrolysis. 
After considerin!{ many steroid inhibitors of 
5a-reductase and finding t hem biologically un-
desirable as antiandrogen ic agents, we found that 
4-androsten-3-o ne-17/3-carboxy lic :~cid l 17PC. 
XVI) fulfills all struct ural requirements for a 
Sa-reductase inhibitor and in our assay it was one 
of the most effect ive inhibitors. It has no known 
hormonal activity and is not found in am natural 
steroidogenic pa.thway. It has been fo~nd as a 
degrada tion product of deoxycortiscosterone in 
perfusates of rat liver (Levy a nd Ma loney. 1962) 
and bovine adrenal (Picha et al., 1952). It would 
seem to be a useful antiandrogen if blocking DH1' 
formation in t he target tissue is an effective means 
of blocking androgen action. 
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ANTlANDROGENIC ACTIVITY OF 
4-ANDROSTEN-3-0NE-17P-CARBOXYLIC ACID AND ITS 
METHYL ESTER ON HAMSTER SEBACEOUS GLAND 
The l1ank organ, or costovertebral spot. of the 
hamster has been shown to be an androgen-
dependent sebaceous st ructure (Hamilton and 
Montagna, 1950). Burdick and Hill (1970) reported 
that topical application of antiandrogenic agents. 
including chlormadi.none acetate and cyproterone 
acetate. to the flank organ of the male animal had 
equivocal effects. However, Frost and Gomez 
(1972) showed that topical application of andro-
genic steroids to the gland of female hamsters 
caused enlargement of the gland and that inhibi-
tion of the androgenic effect by topical antiandro-
gens could be used as an assay for antiandrogen 
activity. This method was used to test the antian-
drogenic property of 17PC and its methyl ester 
(Voigt and Hsia, 1973b). 
Figure 2 shows a photo of the back of a female 
hamster whose left flank organ was treated with 
testosterone propionate in acetone daily for three 
weeks and whose right organ received acetone only. 
Note the enlargement in size and increase in 
pigmentation of the treated organ. Figure 3 shows 
the results in a female whose left f1ank organ 
received daily topical applications of testosterone 
propionate together with 17{3C in acetone for three 
weeks and whose right f1ank organ received only 
acetone. The androgenic effect of testosterone 
propionate was completely blocked by the carbox-
ylic acid. Parallel experiments were carried out 
with the methyl ester of the acid , and antiandro-
genic activity was demonstrated in the same man -
ner. 
Histologic examination of the !lank organ 
treated with testosterone propionate and of the 
organ treated with testosterone propionate plus 
17PC revealed clear differences. The former had 
enlarged sebaceous glands which formed an almost 
continuous mass from follicle to follicle, and the 
sebaceous cells were replete with lipid droplets. In 
contrast, the latter showed undeveloped sebaceous 
FIG. 2: Effect of testosterone propionate on the flank 
organ of a female hamster. 
FIG. 3: Antiandrogenic effect of 17(JC. 
glands. and the individual cells contained less 
lipids. 
In another series of experiments, the f1ank organ 
was treated topically with DHT instead of testos-
terone propionate. As with testosterone propio-
nate, the treated organ became enlarged and in-
creased in pigmentation. The action of DHT could 
not be blocked by 17/jC, an indication that 17PC 
acts in the flank organ as an antiandrogen by in-
hibiting DHT formation. This explanation was 
supported by experiments with homogenates of the 
flank organ. Testosterone 5a-reductase activity 
was demonstrated in the homogenates by the iden-
tification of [ 14C ]DHT and [14C ]5a-androstane-3a,-
l7{J-diol after incubation with ••c testosterone in 
the presence of an NADPH-generating system. 
17PC added to the incubation medium inhibited 
the formation of these Sa-reduced products. 
After our study on the f1ank organ was com-
pleted. a previous publication by Nayfeh and 
Baggett (1969) came to our attention. These inves-
tigators had demonstrated the inhibitory effect of 
the methyl ester of l7PC on the conversion of 
progesterone into androgenic steroids by homage-
nates of rat testis. Thus in addition to its ability to 
inhibit DHT formation in the target tissue, this 
compound can also inhibit androgen formation in 
the gonad. 
CONCLIJSION 
Since DHT is an active form of androgen in 
target tissues, its formation is essential for andro-
gen action. Our findings support t he theory that 
inhibition of DHT formation is an effective means 
of blocking androgen action in target organs. The 
study of the 5a-reductase gave insight into the 
regulation of androgen action and led to the finding 
of a number of inhibitors for the Sa-reductase. 
Knowledge of the necessary structural features in 
these inhibitors assisted us in the selection of 
additional inhibitors, and 17PC was chosen both 
because of its ability to inhibit Sa-reductase activ-
ity and because of the lack of any apparent 
hormonal effects. Its antiandrogenic activity was 
demonstrated after topical application to the seba-
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ceous gland of hamsters. The therapeutic useful-
ness of 17{3C and its deri\·at ives needs to he 
evaluated in further studies. 
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